< Key Hightlight >

MARKET OUTLOOK

Triton Market Research’s report alludes that the infertility testing and treatment market in Europe would grow at a compound annual growth rate of 10.25% during 2021-2028. Spain, Russia, Italy, the United Kingdom, France, Germany, and Rest of Europe form the market in this region.

In Spain, the rising prevalence of polycystic ovary syndrome, thyroid, and premature ovary failure has increased the demand for infertility treatment. Moreover, the overuse of medications like sulfasalazine and anabolic steroids also increases the need for such therapies. Furthermore, the country is among the major destinations for fertility treatment, with the number of patients increasing each year. Besides, the availability of advanced fertility clinics adds to the growth of the studied market. Thus, the rising fertility tourism and presence of well-developed fertility clinics are likely to increase the adoption of infertility treatments, thereby motivating the growth of the infertility testing and treatment market across Spain. 

On the other hand, there is a rising prevalence of health conditions in Italy due to a high level of smoking and drinking. As a result, several conditions, such as high cholesterol, hypertension, respiratory illness, diabetes, and PCOD, are estimated to cause infertility among women. To tackle this issue, the government introduced fertility day to prevent infertility via various programs. One of the campaigns focused on tobacco, drugs, and alcohol abuse and its effects on an individual’s fertility. Hence, such programs are likely to widen the scope and growth of the infertility testing and treatment market across Italy in the upcoming years. 

COMPETITIVE OUTLOOK 

The key companies in the infertility testing and treatment market consist of Cook Medical Inc, Labotect GmbH, EMD Group (Merck KGAA), Bangkok IVF Center, Adorfem, Cooper Surgical, and Genea Ltd.